Department of Gastroenterology and Hepatology, Isala, Zwolle, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Colorectal Dis. 2023 Nov;25(11):2147-2154. doi: 10.1111/codi.16757. Epub 2023 Oct 9.
The colonoscopic-assisted laparoscopic wedge resection (CAL-WR) is proven to be an effective and safe alternative to a segmental colon resection (SCR) for large or complex benign colonic polyps that are not eligible for endoscopic removal. This analysis aimed to evaluate the costs of CAL-WR and compare them to the costs of an SCR.
A single-centre 90-day 'in-hospital' comparative cost analysis was performed on patients undergoing CAL-WR or SCR for complex benign polyps between 2016 and 2020. The CAL-WR group consisted of 44 patients who participated in a prospective multicentre study (LIMERIC study). Inclusion criteria were (1) endoscopically unresectable benign polyps; (2) residual or recurrence after previous polypectomy; or (3) irradically resected low risk pT1 colon carcinoma. The comparison group, which was retrospectively identified, included 32 patients who underwent an elective SCR in the same period.
Colonoscopic-assisted laparoscopic wedge resection was associated with significantly fewer complications (7% in the CAL-WR group vs. 45% in the SCR group, P < 0.001), shorter operation time (50 min in the CAL-WR group vs. 119 min in the SCR group, P < 0.001), shorter length of hospital stay (median length of stay 2 days in the CAL-WR group vs. 4 days in the SCR group, P < 0.001) and less use of surgical resources (reduction in costs of 32% per patient), resulting in a cost savings of €2372 (£2099 GBP) per patient (P < 0.001).
Given the clinical and financial benefits, CAL-WR should be recommended for complex benign polyps that are not eligible for endoscopic resection before major surgery is considered.
对于不符合内镜切除条件的大型或复杂良性结肠息肉,结肠镜辅助腹腔镜楔形切除术(CAL-WR)已被证明是一种安全有效的节段结肠切除术(SCR)替代方法。本分析旨在评估 CAL-WR 的成本,并将其与 SCR 的成本进行比较。
对 2016 年至 2020 年间因复杂良性息肉而行 CAL-WR 或 SCR 的患者进行了一项单中心 90 天“住院”成本比较分析。CAL-WR 组由 44 名参与前瞻性多中心研究(LIMERIC 研究)的患者组成。纳入标准为:(1)内镜下不可切除的良性息肉;(2)既往息肉切除后残留或复发;或(3)经根治性切除的低危 pT1 结肠癌。对照组为同期行选择性 SCR 的 32 例患者,为回顾性确定。
CAL-WR 与更少的并发症相关(CAL-WR 组为 7%,而 SCR 组为 45%,P<0.001)、更短的手术时间(CAL-WR 组为 50 分钟,而 SCR 组为 119 分钟,P<0.001)、更短的住院时间(CAL-WR 组的中位住院时间为 2 天,而 SCR 组为 4 天,P<0.001)和更少的手术资源使用(每位患者成本降低 32%),从而使每位患者节省 2372 欧元(2099 英镑)的费用(P<0.001)。
鉴于其临床和经济效益,在考虑进行重大手术之前,对于不符合内镜切除条件的复杂良性息肉,应推荐使用 CAL-WR。